iTeos Belgium SA
3Patents
3Active
3Granted
43Portfolio score
Filing activity: May 15, 2019 → Sep 9, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11439705B2 | Anti-TIGIT antibodies | Emerging Cross-Sectional Technologies | 1 | Active |
| US11427594B2 | Non brain penetrant A2A inhibitors and methods for use in the treatment of cancers | Chemistry; Metallurgy | 0 | Active |
| US11376255B2 | Thiocarbamate derivatives as A2A inhibitors, pharmaceutical composition thereof and combinations with anticancer agents | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.